Korean J Intern Med.
2000 Jan;15(1):71-75.
The expression of the high mobility group I(Y) mRNA in thyroid cancers: useful
tool of differential diagnosis of thyroid nodules
- Affiliations
-
- 1Department of Internal Medicine, Korea University, Seoul, Korea.
- 2Department of General Surgery, Dankook University, Cheonan, Korea.
Abstract
OBJECTIVE
Thyroid nodule is frequent and occurs in about 5+ACU- of the general
population. In contrast, thyroid cancer is much less frequent and occurs in
about 5-10+ACU- of thyroid nodules. Distinguishing between benign and malignant
lesions is an important task that is best accomplished by fine needle
aspiration. Recently, Chiappetta et al. reported that the expression of the high
mobility group (HMG) I(Y) proteins correlates with the malignant phenotype of
human thyroid neoplasia, and suggested that the detection of the HMG I(Y)
proteins might be a valid tool for an easy and sensitive discrimination assay
between benign and malignant neoplastic thyroid disease. METHODS: We evaluated
the expression of the HMG I(Y) mRNA in 39 frozen thyroid tissues from patients
with thyroid nodule by semiquantitative RT-PCR. RESULTS: The expression of the
HMG I(Y) mRNA was low in all of 10 normal thyroid tissues. In all of 3
adenomatous goiters, 6 follicular adenomas and 2 Hurthle cell adenomas, the HMG
I(Y) mRNA expression level was low. In 11 of 13 papillary carcinomas and all of
5 follicular carcinomas, the HMG I(Y) mRNA expression level was high.
CONCLUSION: These results indicate that there is a correlation between the
expression of HMG I(Y) and the malignant phenotype of thyroid cancer, suggesting
that these proteins may be useful as a marker in thyroid cancer.